Part 1: Abilify
Abilify- A Dangerous and Harmful Drug that Never Should have been brought to Market
As we work to make psychiatric and mental health care legal, safer, more grounded in truth and more dignified for all, one person and one patient at a time, I invite you to read the first report on the drug Abilify.
Recommendations:
Based on my research and experience with the drug and with the way psychiatry is practiced today, I recommend that the University of Minnesota Medical School and the University of MN/Fairview Hospital become the first medical school and hospital to go on record as no longer issuing first prescriptions of Abilify to their patients.
This will save lives, improve care, and send a message to the marketplace and manufacturers of these drugs that they need to provide safe and effective drugs and that dangerous and harmful drugs will be called out and will not be used. This will send a message that hospitals and medical schools, doctors and medical students have independent inquisitive minds and will investigate what they chose to prescribe.
The medical school can use the studies provided by me and other studies done by the FDA, read about my experience, ask me questions (I can help them with their research and can meet with the students and faculty) and come to their own conclusions to support the above recommendations. They can utilize the pharmacy school to study the biochemistry and chemistry of the drug and they can reinforce the previous warnings given by Bristol Myers Squibb about the drug: thirty days in detox. They can demonstrate caring and responsible leadership.
Here is Why:
Bristol Myers Squibb’s antipsychotic Abilify is a dangerous and damaging drug that the FDA should never allowed to be brought to market based on the findings of the original animal drug safety studies completed by the FDA and ensuing studies done by other reputable sources.
According to the FDA studies, Abilify “impacts pituitary and mammary glands, it produced dislocation of the adrenal glands, it caused estrus cycle irregularities and decrease fetal weight at higher doses.” Baby monkeys were born dependent.
It inhibited GI transit in mice, caused a decrease weight in ovaries and uterus, impacted the kidneys liver and spleen and caused an increase in body weight in various animal tests. It also repeatedly caused convulsions and its anesthesia properties were noted. The studies were conclusive there is dependence developed and there is a withdrawal.
The FDA documents show that animals died during the trials and that the cause of death was both directly and indirectly due to the drug’s main ingredient and its mechanism.
Up until 2012, the Bristol Myers Squibb website stated 30 days in detox for the discontinuation of the drug. The Federal Trade Commission has fined Bristol Myers Squibb $490 million dollars for its marketing practices of the drug. The FDA has even come out with a warning that the drug can lead to compulsive behavior.
A British study concluded that even if the mortality of people with schizophrenia is two to three times that of the general population the age standardized death rate in two randomized studies exceeds that pessimistic estimate by 400-500% according to a Cochrane Review.
Additional studies show that its ingredients don
The https://abilifysurvivorsguide.com/ website discusses Abilify in detail and section seven discusses the limitations of the FDA, which is not expressly mandated for safety.
The contents are divided into the following sections:
- Abilify Survivors’ Guide
- Abilify Withdrawal
- Abilify (Aripiprazole) Poisoning
- Abilify Scientific Studies
- Additional Studies
- Survival Tips for Abilify Withdrawal and Poisoning
- Why the Dangers of Abilify Aren’t Common Knowledge
- Why Abilify is Still Being Prescribed
- 10 Action Steps You Can Take
- Abilify Survivor Guide
Duff McDonald, author of The Golden Passport Harvard Business School, the Limits of Capitalism, and the Moral Failure of the MBA Elite has said that “power without responsibility is dangerous.” We now know that neither the FDA nor Bristol Myer Squibb take responsibility for Abilify so we are left with doctors as a check in the system. What better place for true leadership in this arena where others have profited and then abdicated responsibility than a medical school that trains tomorrow’s leaders and a hospital that intersects with people when they are most vulnerable? Let us pray and work for change.